Secondary transitional cell carcinoma and nitrogen mustard treatment

Research output: Contribution to journalArticle

6 Scopus citations

Abstract

Transitional cell carcinoma (TCC) of the bladder in children is a rare occurrence. Cyclophosphamide is a known risk factor for the development of TCC. Other alkylating agents, such as nitrogen mustard, have not been implicated in the development of secondary adult or pediatric TCC. The role of radiotherapy in the development of secondary malignancies of the bladder remains controversial. We report a case of childhood TCC in a patient in remission from Hodgkin's lymphoma previously treated with non-cyclophosphamide chemotherapy and low-dose nodal radiotherapy.

Original languageEnglish (US)
JournalUrology
Volume65
Issue number6
DOIs
StatePublished - Jun 2005

ASJC Scopus subject areas

  • Urology

Fingerprint Dive into the research topics of 'Secondary transitional cell carcinoma and nitrogen mustard treatment'. Together they form a unique fingerprint.

  • Cite this